Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Increased Ketorolac After Cesarean Section
NCT03678675Phase 3Completed
- Sponsor
- Tufts Medical Center
- Start
- May 2019
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketorolac in postoperative pain (2 arms), sponsored by Tufts Medical Center. Primary endpoint: Total Morphine Milligram Equivalents at 72 hours. Started May 2019; status: completed.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03678675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03678675.